NCT00644696 2017-07-06Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory NeuroblastomaUniversity of Michigan Rogel Cancer CenterPhase 1 Completed18 enrolled
NCT00093353 2010-10-15N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant NeuroblastomaChildren's Hospital Los AngelesPhase 1 Completed30 enrolled